Stocktoria
Traws Pharma, Inc. TRAW
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-07-25
Traws Pharma, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% owner | 2026-04-16 | Buy | 597,729 | $1.67 |
| Parker Charles Nolan | Chief Financial Officer | 2025-12-12 | Grant | 15,393 | — |
Source: SEC EDGAR filings · CIK 0001130598 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.